Experts weigh benefits, risks of Allergan-Inamed merger

National report — A proposed $3.2 billion merger of Botox-maker Allergan and breast-implant maker Inamed would ultimately benefit dermatologists, an Allergan official says.

Related Videos
Related Content

What's Trending in Skin Care: May 2023

May 31st 2023

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition

March 26th 2022

Topical Carboxytherapy and Human Platelet Extract Used as Peri-Procedural Adjuvant Following Non-Ablative Laser Resurfacing

May 21st 2023

The Cutaneous Connection: Cosmetic Dermatology: Procedures and Practice

March 17th 2022

Using Creams Containing Macrocystis Pyrifera Ferment for Skin Rejuvenation

May 20th 2023

Glynis Ablon, MD, Reviews the Latest Innovative Treatment Pearls for Hair Loss

May 20th 2023

What's Trending in Skin Care: May 2023

May 31st 2023

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition

March 26th 2022

Topical Carboxytherapy and Human Platelet Extract Used as Peri-Procedural Adjuvant Following Non-Ablative Laser Resurfacing

May 21st 2023

The Cutaneous Connection: Cosmetic Dermatology: Procedures and Practice

March 17th 2022

Using Creams Containing Macrocystis Pyrifera Ferment for Skin Rejuvenation

May 20th 2023

Glynis Ablon, MD, Reviews the Latest Innovative Treatment Pearls for Hair Loss

May 20th 2023

What's Trending in Skin Care: May 2023

May 31st 2023

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition

March 26th 2022

Topical Carboxytherapy and Human Platelet Extract Used as Peri-Procedural Adjuvant Following Non-Ablative Laser Resurfacing

May 21st 2023

The Cutaneous Connection: Cosmetic Dermatology: Procedures and Practice

March 17th 2022

Using Creams Containing Macrocystis Pyrifera Ferment for Skin Rejuvenation

May 20th 2023

Glynis Ablon, MD, Reviews the Latest Innovative Treatment Pearls for Hair Loss

May 20th 2023
© 2023 MJH Life Sciences

All rights reserved.